Health Products

RAN-Imipenem-Cilastatin (2015-12-23)

· Published by Health Canada · Official notice

Details

Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberBrand nameCompaniesDosage formDIN, NPN, DIN-HIMStrength
2686433RAN-Imipenem-Cilastatin
Recalling Firm
Ranbaxy Pharmaceuticals Canada Inc.
126 East Drive
Brampton
L6T 1C1
CANADA
Marketing Authorization Holder
Ranbaxy Pharmaceuticals Canada Inc.
126 East Drive
Brampton
L6T 1C1
CANADA
Powder for solutionDIN 02351692Cilastatin (Cilastatin Sodium) 250mg/vial

Introduction

Affected Products

RAN-Imipenem-Cilastatin

Reason

Out of specification result for an impurity during stability testing.

Depth of distribution

One wholesaler in Quebec distributing to hospitals.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime